| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2015 | EP2834230A1 Carboxamide compounds and their use as calpain inhibitors v |
| 02/11/2015 | EP2834228A1 N- substituted hetero - bicyclic furanone derivatives for combating animal |
| 02/11/2015 | EP2834227A1 Novel triazole compounds that modulate hsp90 activity |
| 02/11/2015 | EP2834226A1 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators |
| 02/11/2015 | EP2834224A2 Process for the preparation of benzimidazole derivatives and salts thereof |
| 02/11/2015 | EP2834223A2 (1,2,3-triazolyl) sulfonyl derivatives |
| 02/11/2015 | EP2834222A1 A new class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as mri contrast agents |
| 02/11/2015 | EP2834221A1 Cyclic amides as metap-2 inhibitors |
| 02/11/2015 | EP2834220A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
| 02/11/2015 | EP2834219A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one |
| 02/11/2015 | EP2834216A1 Selective androgen receptor modulators |
| 02/11/2015 | EP2833973A1 Compounds useful as inhibitors of atr kinase and combination therapies thereof |
| 02/11/2015 | EP2833922A2 In vivo production of proteins |
| 02/11/2015 | EP2833917A1 Tyrosine kinase inhibitor combinations and their use |
| 02/11/2015 | EP2833914A1 Improved adjuvant system for oral vaccine adminstration |
| 02/11/2015 | EP2833905A1 Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane |
| 02/11/2015 | EP2833904A1 Food supplement to support brain function |
| 02/11/2015 | EP2833895A1 Preventing or treating periodontal disease |
| 02/11/2015 | EP2833894A1 Modified polynucleotides for the production of cosmetic proteins and peptides |
| 02/11/2015 | EP2833893A1 Stem cell microparticles |
| 02/11/2015 | EP2833892A2 Modified polynucleotides for the production of oncology-related proteins and peptides |
| 02/11/2015 | EP2833891A1 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion |
| 02/11/2015 | EP2833890A1 Fe(iii)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia |
| 02/11/2015 | EP2833889A1 Protein kinase c inhibitors and uses thereof |
| 02/11/2015 | EP2833888A1 Composition and method for corneal proliferation |
| 02/11/2015 | EP2833887A1 An h3 receptor antagonist for use in the treatment of alzheimer's disease |
| 02/11/2015 | EP2833886A1 Substituted quinolines as bruton's tyrosine kinases inhibitors |
| 02/11/2015 | EP2833884A1 Use of ccr3-inhibitors |
| 02/11/2015 | EP2833883A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment |
| 02/11/2015 | EP2833882A1 Ketone bodies and ketone body esters for maintaining or improving muscle power output |
| 02/11/2015 | EP2833881A1 Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof |
| 02/11/2015 | EP2833880A1 Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer |
| 02/11/2015 | EP2833879A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 02/11/2015 | EP2833878A1 Local composition to treat stress urinary incontinence in a female subject |
| 02/11/2015 | EP2833877A1 Novel targeting agents for diagnostic and therapeutic indications |
| 02/11/2015 | EP2833876A1 Compositions and methods comprising toll like receptor (tlr) stimulating agents for prophylaxis and therapy for damage to dermal epithelium |
| 02/11/2015 | EP2833875A1 A dopamine-agonist-containing transdermal application system |
| 02/11/2015 | EP2833874A1 Capsule formulations comprising ceftibuten |
| 02/11/2015 | EP2833873A1 Film tablet formulations comprising cefuroxime axetil and clavulanic acid |
| 02/11/2015 | EP2833872A1 Tablet formulations comprising cefpodoxime proxetil and clavulanic acid |
| 02/11/2015 | EP2833871A1 Prasugrel-containing immediate release stable oral pharmaceutical compositions |
| 02/11/2015 | EP2833868A1 Oral liquid concentrate comprising brompheniramine, pseudoephedrine and dextromethorphan |
| 02/11/2015 | EP2833865A1 Treatment of proliferative diseases with pyrimidodiazepinones |
| 02/11/2015 | EP2833864A1 Pharmaceutical formulations comprising ccr3 antagonists |
| 02/11/2015 | CN104350057A 用作治疗剂的螺-羟吲哚化合物的不对称合成 As therapeutic agents for snails - Asymmetric Synthesis oxindole compounds |
| 02/11/2015 | CN104350056A 端锚聚合酶的吡咯并嘧啶酮和吡咯并吡啶酮抑制剂 Tankyrase pyrrolo pyrimidinone and pyridone inhibitors pyrrolo |
| 02/11/2015 | CN104350055A 作为mnk1和mnk2调节剂的二环杂芳基衍生物及其用途 As mnk1 and mnk2 modulators bicyclic heteroaryl derivatives and their use |
| 02/11/2015 | CN104350054A 作为选择性细胞周期蛋白依赖性激酶抑制剂的吡唑并-三嗪衍生物 As a selective cyclin-dependent kinase inhibitors pyrazolo - triazine derivative |
| 02/11/2015 | CN104350053A 杂芳族甲基环胺衍生物 Heteroaromatic methyl cyclic amine derivative |
| 02/11/2015 | CN104350052A 一氧化氮供体脑啡肽酶抑制剂 Nitric oxide donor neprilysin inhibitor |
| 02/11/2015 | CN104350049A 作为激酶抑制剂的取代氨基喹唑啉 As kinase inhibitors substituted aminoquinazolinone |
| 02/11/2015 | CN104350047A 作为钙敏感受体调节剂的取代苯并二氢吡喃化合物 As the calcium-sensing receptor modulators substituted chroman compound |
| 02/11/2015 | CN104350046A 6-o-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇草酸盐的多晶型盐及其制备和使用方法 6-o- (4- dimethylamino-ethoxy) cinnamoyl polymorph salts and methods of making and using fumagillol oxalate |
| 02/11/2015 | CN104350045A 用于治疗涉及调节兰诺定受体的调节障碍的活性剂 For the treatment involves adjusting the ryanodine receptor dysregulation of active agent |
| 02/11/2015 | CN104350042A 脑啡肽酶抑制剂 Neprilysin inhibitor |
| 02/11/2015 | CN104350041A 用于治疗神经系统疾病的组合物和方法 Compositions and methods for treating neurological disorders |
| 02/11/2015 | CN104350040A 芳环化合物 Aromatic compounds |
| 02/11/2015 | CN104349793A 寡核苷酸螯合物-多肽组合物和方法 Oligonucleotide chelate - polypeptide compositions and methods |
| 02/11/2015 | CN104349792A 帕潘立酮植入物制剂 Paliperidone implant formulations |
| 02/11/2015 | CN104349790A 用于治疗糖尿病的葡萄糖激酶活化剂组合物 For treating diabetes glucokinase activator composition |
| 02/11/2015 | CN104349784A 动物饲料组合物及使用其的方法 Animal feed composition and method of use thereof |
| 02/11/2015 | CN104349783A 治疗肺部感染的系统 Treatment of pulmonary infection system |
| 02/11/2015 | CN104349782A 囊泡制剂 Vesicle preparation |
| 02/11/2015 | CN104349781A 用于减轻炎性疼痛或相关病症的包含唑来膦酸或相关化合物的组合物 The composition for reducing inflammatory pain or a related disorder comprising zoledronic acid or related compounds |
| 02/11/2015 | CN104349780A 含有吡罗昔康或其药学上可接受的盐和透明质酸或其药学上可接受的盐的稳定液体药学组合物及其制造方法 Stable liquid pharmaceutical composition and method of manufacturing acceptable salt thereof and a pharmaceutically acceptable hyaluronic acid or a pharmaceutically piroxicam or a salt thereof comprising |
| 02/11/2015 | CN104349779A Pi-3激酶抑制剂的剂量方案 Pi-3 kinase inhibitor dosage regimen |
| 02/11/2015 | CN104349778A 在失血和贫血治疗中用于防止血管活性的组合物 Compositions in the treatment of blood loss and anemia for preventing vasoactive |
| 02/11/2015 | CN104349777A 用于治疗脊髓性肌萎缩的化合物 Compound treatment for spinal muscular atrophy |
| 02/11/2015 | CN104349776A 新的剂量和制剂 New dose and formulation |
| 02/11/2015 | CN104349775A Jak1和jak2的抑制剂 Jak1 and jak2 inhibitors |
| 02/11/2015 | CN104349774A 取代的吡咯烷-2-甲酰胺 Substituted pyrrolidine-2-carboxamide |
| 02/11/2015 | CN104349773A 用于治疗代谢性病症的组合物和方法 Compositions and methods for treating metabolic disorders |
| 02/11/2015 | CN104349772A 用于治疗炎症和疼痛的化合物 Treatment of inflammation and pain for compound |
| 02/11/2015 | CN104349771A 用于治疗肿瘤疾病的17α-羟化酶(C17,20-裂解酶)抑制剂和特定PI-3K抑制剂的组合 For the treatment of neoplastic diseases 17α- hydroxylase (C17,20- cleaving enzyme) inhibitors and specific PI-3K inhibitor combination |
| 02/11/2015 | CN104349770A 透析组合物 Dialysis composition |
| 02/11/2015 | CN104349769A 医用有机凝胶方法和组合物 Medical methods and compositions of the organogel |
| 02/11/2015 | CN104349768A 包含阿朴吗啡和有机酸的组合物及其用途 Containing apomorphine and organic compositions and their use |
| 02/11/2015 | CN104349676A 用于治疗自闭症的方法和组合物 Method for the treatment of autism and compositions |
| 02/11/2015 | CN104342479A 半乳糖凝集素-7产生抑制剂 Galectin inhibitor produced -7 |
| 02/11/2015 | CN104342444A 一种重组trail蛋白及其制备方法和用途 A recombinant protein and trail preparation and use |
| 02/11/2015 | CN104341591A 蒽环类药物偶联非线性多嵌段共聚物及其制备方法和应用 Anthracyclines coupled nonlinear multi-block copolymer and its preparation method and application |
| 02/11/2015 | CN104341590A 一种树枝状高分子化合物及其制备和用途 A branched polymer compounds and their preparation and use |
| 02/11/2015 | CN104341504A 双特异性抗体 Bispecific antibody |
| 02/11/2015 | CN104341482A 一种杂环磺酸衍生物的合成及其在药物治疗中的应用 Synthesis of a heterocyclic sulfonic acid derivatives and their use in drug therapy |
| 02/11/2015 | CN104341481A 一种磺酰胺化合物的合成和应用 Synthesis and Application of a sulfonamide compound |
| 02/11/2015 | CN104341471A 大环内酯类化合物或其盐、合成方法、药物组合物及其应用 Macrolide compound or a salt thereof, synthetic methods, pharmaceutical compositions and use |
| 02/11/2015 | CN104341451A 新磷酸酯化合物、其制备方法及含有它们的药物组合物 New phosphate compounds, their preparation and pharmaceutical compositions containing them |
| 02/11/2015 | CN104341450A 一种磺酰胺衍生物的合成与药学应用 Synthesis and Application of a pharmaceutically sulfonamide derivative |
| 02/11/2015 | CN104341437A 含有双环基团的syk抑制剂 Containing bicyclic group of syk inhibitor |
| 02/11/2015 | CN104341434A 取代的雷帕霉素三氮唑衍生物和用途 Substituted triazole derivative of rapamycin and uses |
| 02/11/2015 | CN104341430A 一种土甘草a及其提取方法和用途 One kind of soil and licorice extract a method and use |
| 02/11/2015 | CN104341425A 氘代乙炔衍生物、其药物组合物及应用 Deuterated acetylene derivatives, pharmaceutical compositions and applications |
| 02/11/2015 | CN104341423A 替格瑞洛的一水合物及其制备方法与在制药中的应用 Ticagrelor monohydrate and its preparation method and application in pharmacy |
| 02/11/2015 | CN104341416A 蛋白酪氨酸激酶抑制剂及其应用 Protein tyrosine kinase inhibitors and their applications |
| 02/11/2015 | CN104341415A 一种黄藤素酰腙类衍生物及其制备方法和用途 One kind Palmatine acylhydrazone derivatives and its preparation method and use |
| 02/11/2015 | CN104341407A 喹唑啉类化合物及其制备方法和用途 Quinazoline compounds and their preparation and use |
| 02/11/2015 | CN104341405A 一种具有抑制Aβ聚集活性的化合物的制备方法与用途 Kind of compounds that inhibit the activity of Aβ aggregation of preparation and use |
| 02/11/2015 | CN104341404A 异黄酮类衍生物及其制备方法和应用 Isoflavone derivatives and its preparation method and application |
| 02/11/2015 | CN104341401A C型肝炎病毒复制的新型抑制剂 Novel inhibitors of hepatitis C virus replication |
| 02/11/2015 | CN104341397A 具晶型的依来曲普坦自由碱及其制法和应用 A crystalline form according to triptans free base preparation method and application |